External and implantable insulin pumps: Current place in the treatment of diabetes

Experimental and Clinical Endocrinology and Diabetes

Volumn 109, Issue SUPPL. 2, 2001, Pages

  Selam, J L ^a  

^a HÔTEL DIEU   (France)

Author keywords

CSII; External pumps; Implantable pumps; Peritoneum

Indexed keywords

INSULIN;

ARTICLE; DIABETES MELLITUS; DRUG DELIVERY SYSTEM; DRUG EFFICACY; HUMAN; IMPLANT; INSULIN PUMP; PATIENT SATISFACTION; PRIORITY JOURNAL; TREATMENT INDICATION;

DIABETES MELLITUS; EQUIPMENT DESIGN; HUMANS; INFUSION PUMPS; INSULIN; PROSTHESES AND IMPLANTS;

EID: 0034972854     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-18592     Document Type: Article

References (37)

1. One to five days of continuous intravenous insulin infusion on seven diabetic patients
2. Le traitement par pompe portable à insuline en France: Résultats de l'enquête Infusystèmes
3. Insulin lispro in CSII: Results of a double-blind crossover study
4. Improvement of HbA1c and blood glucose stability in IDDM patients treated with lispro insulin analog in external pumps
5. Use of insulin lispro in continuous subcutaneous insulin infusion treatment
6. Hypoglycemia in the diabetes control and complications trial
7. Insulinothérapie intensive du diabète instable par pompe à insuline
8. Reduction in severe hypoglycemia with long-term continuous subcutaneous insulin infusion in type 1 diabetes
9. How to ameliorate the problem of hypoglycemia in intensive as well as nonintensive treatment of type 1 diabetes
10. A prospective study identifying risk factors for discontinuance of insulin pump therapy
11. Efficacy and indications of CSII revisited: The Hôtel-Dieu cohort
12. Recommandations de l'Alfediam: Pompes portables à insuline
13. La place actuelle des pompes externes dans le traitement du diabète insulino-dépendant
14. Extreme insulin resistance: Clinical management by external subcutaneous insulin infusion
15. In search of the subcutaneous-insulin-resistance syndrome
16. Comment quantifier l'instabilité glycémique?
17. Coûtbénéfice de l'insulinothérapie intensive par injections, pompe externe et pompe implantable
18. Continuous subcutaneous insulin infusion
19. Pompe MEDIPAD
20. Les pompes implantables à insuline ont-elles un intérêt autre qu'expérimental?
21. Implantable insulin pumps
22. Symptoms, hormones and glucose fluxes during a gradual hypoglycaemia induced by intraperitoneal vs venous insulin infusion in type 1 diabetes
23. Utilisation des pompes à insuline implantables: La position d'EVADIAC
24. Feasibility of intraperitoneal insulin therapy with programmable implantable pumps in IDDM
25. Frenche multicentre experience of implantable insulin pumps
26. Long-term therapy of IDDM with an implantable insulin pump
27. A cost-benefit comparison of intensive diabetes management with implantable pumps versus multiple subcutaneoux injections in patients with type 1 diabetes
28. Deacreased severe hypoglycemia frequency during intraperitoneal insulin infusion using programmable implantable pumps
29. Implantable insulin pump vs multiple-dose insulin for non-insulin-dependent diabetes mellitus. A randomized clinical trial
30. Local adverse events associated with long-term treatment by implantable insulin pumps
31. Insulin underdelivery from implanted pumps using peritoneal route
32. Implantable infusion pump management of insulin resistant diabetes mellitus
33. The management of severe brittle diabetes with «In-fusaid» implantable pumps
34. Course of brittle diabetes: 12 Year follow up
35. Management of «brittle» diabetes with a preprogrammable implanted insuli pump delivering intraperitoneal insulin
36. Successful pregnancy in severe diabetes
37. Implanted insulin pump may represent a change for young women with unstable type 1 diabetes to get a baby